The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ken Shinmura, Roberto Bolli

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)617; author reply 617-618
JournalAnnals of internal medicine
Volume143
Issue number8
Publication statusPublished - 2005 Oct 18

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Shinmura, K., & Bolli, R. (2005). The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Annals of internal medicine, 143(8), 617; author reply 617-618.